Mechanisms of Action and Therapeutic Applications of Biologicals in Cancer and Immune Deficiency Disorders

Partial table of contents: HEMATAPOIETIC GROWTH FACTORS. Experience with Recombinant Human Erythropoietin in Man: An Update (J. Adamson & J. Eschbach). Expression of CSF-1 Receptors on Human Leukemic Blasts (R. Ashmun, et al.). INTERLEUKINS. Pathophysiology of the Acute Phase Response to IL-2 Immunotherapy (J. Mier, et al.). Perspectives for Cellular Immunotherapy of Cancer: Building Upon Regimens Using Tolerable Doses of Interleukin-2 (IL-2) (P. Sondel, et al.). MONOCLONAL ANTIBODIES. Treatment of Human B-Cell Lymphoma with Anti-CD19 Monoclonal Antibody and with a Combination of Anti-CD19 and IL-2 (A. Hekman, et al.). NKCF: Its Characteristics and Potential Therapeutic Uses (J. Ortaldo). AIDS. Second Generation Antiviral Therapy Against Human Immunodeficiency Virus (HIV) (H. Mitsuya & S. Broder). Development of Recombinant Soluble CD4 as a Novel HIV Antiviral (R. Fisher, et al.). Index.Evans, Charles H. is the author of 'Mechanisms of Action and Therapeutic Applications of Biologicals in Cancer and Immune Deficiency Disorders', published 1990 under ISBN 9780471562207 and ISBN 0471562203.